as on September 13, 2025 at 1:26 am IST
Day's Low
Day's High
0.41%
Downside
3.51%
Upside
52 Week's Low
52 Week's High
79.36%
Downside
44.33%
Upside
Check Alterity Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$76.7M
EPS (TTM)
-0.82
Dividend Yield
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0Return On Equity TTM
7916600.00%
Compare market cap, revenue, PE, and other key metrics of Alterity Therapeutics Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $76.7M | -75.96% | NA | -223.35% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Alterity Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Alterity Therapeutics Ltd investment value today
Current value as on today
₹3,90,036
Returns
₹2,90,036
(+290.04%)
Returns from Alterity Therapeutics Ltd Stock
₹2,84,921 (+284.92%)
Dollar Returns*
₹5,115 (+5.12%)
Search interest for Alterity Therapeutics Ltd Stock has decreased by -73% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 802.96K → 1.60M (in $), with an average increase of 50.0% per quarter
Best in 1 Year
In the last 1 year, ATHE has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 1 year, ATHE stock has moved up by 288.9%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 141.2%
Profit Down
Netprofit is down for the last 2 quarters, -3.58M → -7.17M (in $), with an average decrease of 100.0% per quarter
Organisation | Alterity Therapeutics Ltd |
Headquarters | 350 Collins Street, Melbourne, VIC, Australia, 3000 |
Industry | Biotechnology |
CEO | Dr. David A. Stamler M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Geoffrey Paul Kempler B.Sc. | Co-Founder & Non-Executive Chairman |
Dr. David A. Stamler M.D. | Chief Executive Officer |
Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A. | CFO & Company Secretary |
Dr. Rudolph Emile Tanzi Ph.D. | Chief Scientific Advisor and Member of Research & Development Advisory Board |
Dr. Steven D. Targum M.D. | Chief Medical Advisor |
Dr. Robert Cherny | Head of Research |
Alterity Therapeutics Ltd share price today is $4.85 as on at the close of the market. Alterity Therapeutics Ltd share today touched a day high of $5.02 and a low of $4.83.
Alterity Therapeutics Ltd share touched a 52 week high of $7 on and a 52 week low of $1 on . Alterity Therapeutics Ltd stock price today i.e. is closed at $4.85,which is 30.71% down from its 52 week high and 384.52% up from its 52 week low.
Alterity Therapeutics Ltd market capitalisation is $0.00T as on .
Indian investors can start investing in Alterity Therapeutics Ltd (ATHE) shares with as little as ₹88.25 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Alterity Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Alterity Therapeutics Ltd share’s latest price of $4.85 as on September 13, 2025 at 1:26 am IST, you will get 2.0619 shares of Alterity Therapeutics Ltd. Learn more about
fractional shares .
Alterity Therapeutics Ltd stock has given -75.96% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?